Screening for 'prelysosomal disorders': Carbohydrate-deficient glycoprotein syndromes

Journal of Child Neurology

Volumn 14, Issue SUPPL. 1, 1999, Pages

  Patterson, Marc C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CEREBROSIDE SULFATASE; GLYCOPROTEIN; OLIGOSACCHARIDE; PLASMA PROTEIN; TRANSFERRIN;

ARTICLE; CONGENITAL DISORDER OF GLYCOSYLATION; GLYCOSYLATION; HUMAN; ISOELECTRIC FOCUSING; MUTATION; PHENOTYPE; PRIORITY JOURNAL; SCREENING;

EID: 0032726532     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073899014001041     Document Type: Article

References (36)

1. Jaeken J, Carchon H: The carbohydrate-deficient glycoprotein syndromes: An overview. J Inherit Metab Dis 1993;16:813-820.
2. Reitman ML, Varki A, Kornfeld S: Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in undine 5′-diphosphate-N-acetylglucosamine:glycoprotein N-acetyl-glucosaminyl phosphotransferase activity. J Clin Invest 1981;67: 1574-1579.
3. Fukuda MN, Masri KA, Dell A, et al: Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II (HEMPAS) caused by a gene defect encoding alpha-mannosidase II. Proc Natl Acad Sci USA 1990;87:7443-7447.
4. Kremmidiotis G, Lensink IL, Bilton RL, et al: The Batten disease gene product (CLN3p) is a Golgi integral membrane protein. Hum Mol Genet 1999;8:523-531.
5. Varki A: Biologic roles of oligosaccharides: All of the theories are correct. Glycobiology 1993;3:97-130.
6. Sabatini DD, Adesnik MB: The biogenesis of membranes and organelles, in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Molecular and Metabolic Bases of Inherited Disease, vol 1. New York, McGraw-Hill, 1995, pp 459-553.
7. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, et al: Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulfatase A and increased CSF protein: A new syndrome? Pediatr Res 1980;14:179.
8. Jaeken J, van Eijk HG, van der Heul C, et al: Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 1984;144:245-247.
9. Jaeken J, Stibler H, Hagberg B: The carbohydrate-deficient glycoprotein syndrome: A new inherited multisystemic disease with severe nervous system involvement. Acta Pediatr Scand 1991; 375(Suppl):1-71.
10. Yuasa I, Ohno K, Hashimoto K, et al: Carbohydrate-deficient glycoprotein syndrome: Electrophoretic study of multiple serum glycoproteins. Brain Dev 1995;17:13-19.
11. Jaeken J, Casaer P: Carbohydrate-deficient glycoconjugate syndromes: A new chapter of neuropediatrics. Eur J Pediatr Neurol 1997;2/3:61-66.
12. Stibler H, Cederberg B: Diagnosis of the carbohydrate-deficient glycoprotein syndrome by analysis of transferrin in filter paper blood spots. Acta Paediatr 1993;82:55-59.
13. Stibler H, von Dobeln U, Kristiansson B, Guthenberg C: Carbohydrate-deficient transferrin in galactosaemia. Acta Paediatr 1997;86:1377-1378.
14. Jaeken J, Pirard M, Adamowicz M, et al: Inhibition of phosphomannose isomerase by fructose 1-phosphate: An explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res 1996;40:764-766.
15. Clayton P, Winchester B, Di Tomaso E, et al: Carbohydrate-deficient glycoprotein syndrome: Normal glycosylation in the fetus, letter. Lancet 1993;341:956.
16. Van Schaftingen E, Jaeken J: Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 1995;377:318-320.
17. Tan J, Dunn J, Jaeken J, Schachter H: Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet 1996;59: 810-817.
18. Burda P, Borsig L, de Rijk-van Andel J, et al: A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest 1998;102:647-652.
19. Korner C, Knauer R, Holzbach U, et al: Carbohydrate-deficient glycoprotein syndrome type V: Deficiency of dolichyl-P-Glc:Man9 GlcNAc2-PP-dolichyl glucosyltransferase. Proc Natl Acad Sci U S A 1998;95:13200-13205.
20. Stibler H, Westerberg B, Hanefeld F, Hagberg B: Carbohydrate-deficient glycoprotein (CDG) syndrome - a new variant, type III. Neuropediatrics 1993;24:51-52.
21. Stibler H, Stephani U, Kutsch U: Carbohydrate-deficient glycoprotein syndrome - a fourth subtype. Neuropediatrics 1995;26: 235-237.
22. Barone R, Carchon H, Jansen E, et al: Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency). J Inherit Metab Dis 1998;21:167-172.
23. Jaeken J, Matthijs G, Barone R, Carchon H: Carbohydrate deficient glycoprotein (CDG) syndrome type I. J Med Genet 1997;34:73-76.
24. Jaeken J, Besley G, Buist N, et al: Phosphomannosmutase deficiency is the major cause of carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab Dis 1996;19:6.
25. Matthijs G, Schollen E, Pardon E, et al: Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type 1 syndrome (Jaeken syndrome). Nat Genet 1997;16:88-92.
26. Schollen E, Pardon E, Heykants L, et al: Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: The sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene. Hum Mol Genet 1998; 7:157-164.
27. Niehues R, Hasilik M, Alton G, et al: Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998;101:1414-1420.
28. de Koning TJ, Dorland L, van Diggelen OP, et al: A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun 1998;245:38-42.
29. De Lonlay P, Cuer M, Barrot S, et al: Hyperinsulinemic hypoglycemia as a presenting symptom in phosphomannose isomerase deficiency: A new presentation of carbohydrate-deficient glycoprotein syndrome treatable by mannose, abstract. J Inherit Metab Dis 1998;21(Suppl 2):96.
30. van Diggelen OP, Maat-Kievet JA, de Klerk JBC, et al: Two more Dutch cases of CDG syndrome 1b: Phosphomannose isomerase deficiency, abstract. J Inherit Metab Dis 1998;21(Suppl 2):97.
31. Stibler H, Blennow G, Kristiansson B, et al: Carbohydrate-deficient glycoprotein syndrome: Clinical expression in adults with a new metabolic disease. J Neurol Neurosurg Psychiatry 1994;57: 552-556.
32. Kristiansson B, Stibler H, Wide L: Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Acta Paediatr 1995;84:655-659.
33. Macchia PE, Harrison HH, Scherberg NH, et al: Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I. J Clin Endocrinol Metab 1995;80:3744-3749.
34. Garel C, Baumann C, Besnard M, et al: Carbohydrate-deficient glycoprotein syndrome type I: A new cause of dysostosis multiplex. Skeletal Radiol 1998;27:43-45.
35. Stibler H, Holzbach U, Tengborn L, Kristiansson B: Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type I. Blood Coagul Fibrinolysis 1996;7:118-126.
36. Young G, Driscoll MC: Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: Case report and review of the literature. Am J Hematol 1999;60:66-69.